Hims & Hers Health Inc. (HIMS) experienced a 6% decline following a downgrade by Morgan Stanley (MS). Despite the drop, some investors view the stock as overbought but still consider it a strong long-term investment, with a potential dip back to $50 seen as a buying opportunity. The stock's recent performance has been compared to other successful IPOs like Reddit (RDDT) and Cava Group (CAVA), suggesting a positive outlook for long-term holders. Meanwhile, Palantir Technologies Inc. (PLTR) reached a new all-time high, with market observers noting significant interest and confidence in the stock as it approaches resistance levels around $125, with a 400K call option wall and substantial selling of May $120 puts indicating strong market sentiment. Some speculate that PLTR could target $100 per share.